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Abstract
Background: Clinical results of regenerative treatments for osteoarthritis are becoming 
increasingly significant. However, several questions remain unanswered concerning 
mesenchymal stem cell (MSC) adhesion and incorporation into cartilage. Methods: To this end, 
peripheral blood (PB) MSCs were chondrogenically induced and/or stimulated with pulsed 
electromagnetic fields (PEMFs) for a brief period of time just sufficient to prime differentiation. 
In an organ culture study, PKH26 labelled MSCs were added at two different cell densities (0.5 
x106 vs 1.0 x106). In total, 180 explants of six horses (30 per horse) were divided into five groups: 
no lesion (i), lesion alone (ii), lesion with naïve MSCs (iii), lesion with chondrogenically-induced 
MSCs (iv) and lesion with chondrogenically-induced and PEMF-stimulated MSCs (v). Half of 
the explants were mechanically loaded and compared with the unloaded equivalents. Within 
each circumstance, six explants were histologically evaluated at different time points (day 1, 
J.H. Spaas and S.Y. Broeckx share first authorship. A. Franco-Obregón and K. Wuertz-Kozak share last 
authorship.
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5 and 14). Results: COMP expression was selectively increased by chondrogenic induction 
(p = 0.0488). PEMF stimulation (1mT for 10 minutes) further augmented COL II expression 
over induced values (p = 0.0405). On the other hand, MSC markers remained constant over 
time after induction, indicating a largely predifferentiated state. In the unloaded group, MSCs 
adhered to the surface in 92.6% of the explants and penetrated into 40.7% of the lesions. 
On the other hand, physiological loading significantly reduced surface adherence (1.9%) and 
lesion filling (3.7%) in all the different conditions (p < 0.0001). Remarkably, homogenous cell 
distribution was characteristic for chondrogenic induced MSCs (+/- PEMFs), whereas clump 
formation occurred in 39% of uninduced MSC treated cartilage explants. Finally, unloaded 
explants seeded with a moderately low density of MSCs exhibited greater lesion filling (p = 
0.0022) and surface adherence (p = 0.0161) than explants seeded with higher densities of 
MSCs. In all cases, the overall amount of lesion filling decreased from day 5 to 14 (p = 0.0156). 
Conclusion: The present study demonstrates that primed chondrogenic induction of MSCs at 
a lower cell density without loading results in significantly enhanced and homogenous MSC 
adhesion and incorporation into equine cartilage.
IntroductionOsteoarthritis, also known as degenerative joint disease (DJD), is a pathology characterized by degenerative and sometimes hypertrophic changes of bone and cartilage, resulting in progressive apposing of joint surfaces causing pain and joint distortion. In the US between the years of 2010 and 2012, 52.5 million adults (22.7%) demonstrated doctor-diagnosed arthritis [1]. By 82 years of age, as high as 50% of the population will develop knee osteoarthritis [2], with greater morbidity in modern societies [3]. Also in horses, 60% of locomotory disorders are correlated with osteoarthritis [4], which is considered a major economic loss for the industry [5, 6].The evolutionary distance between human and rhesus monkey genome is estimated to be around 35 million years, whereas this would be 80 million years for rodents [7]. Large animals, such as horses and dogs, are located somewhere in between [8]. Histological 
evaluation of horse, goat, sheep, dog, and rabbit stifle joint cartilage demonstrated closest 
proximity of equine stifle cartilage to its human equivalent [9]. Therefore, horses may be considered as a relevant pre-clinical animal model for human therapies. Also the FDA reported in 2005 the use of equine cartilage studies for assessing clinical endpoints in human clinical trials [10].
Recently, it has been shown that pulsed electromagnetic field (PEMF) treatment of 
injured rabbit knees can significantly improve histological scores and hyaline cartilage 
formation after 6 weeks of daily PEMF treatment for one hour a day [11]. In 28 elderly humans with bilateral knee osteoarthritis, PEMF stimulation at 3 times per week over 6 
weeks significantly improved pain, stiffness, and physical function in comparison to the untreated contralateral joint [12]. Trock et al. found that treating human patients with knee 
osteoarthritis (n=86) with PEMFs for a total of 18 times caused significant differences in pain, pain on motion, and tenderness in comparison to placebo treatments [13]. Interestingly, 
PEMF stimulation of human umbilical cord-derived mesenchymal stem cells (MSCs) was able to enhance proliferation and accelerate chondrogenic differentiation and extracellular matrix production in vitro [14] and similar beneficial effects were observed for adipose-
derived MSCs in both, 2D and 3D culture [15].It was shown that experimentally induced cartilage lesions in horses treated with 
autologous adipose tissue or bone marrow-derived MSCs in combination with hyaluronic 
acid or fibrin hydrogels revealed only modest clinical improvements in comparison to the 
placebo treatment group, however, with enhanced tissue repair and increased ACAN levels 
[16-18]. Rather than using uninduced MSCs, several researchers have chosen to perform 
 Copyright © 2015 S. Karger AG, Basel
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chondrogenic predifferentiation of MSCs, which resulted in enhanced therapeutic effects [19-21].
In order to provide more insights in the aforementioned findings, the present study consists of a series of combined cell culture and organ culture experiments. Firstly, equine 
peripheral blood (PB) MSCs were exposed to chondrogenic induction with and without 
PEMF treatment and changes in the mRNA expression of chondrogenic markers relative 
to untreated PB-MSCs was analysed after 6, 24 and 72 hours (n=3). In the second part, 
lesions were introduced into stifle joint cartilage explants of six horses, followed by topical 
application of allogeneic PB-MSCs obtained from one donor horse, at two different seeding densities. Five different groups were considered at three time points (day 1, 5 and 14) with 
or without loading: no lesion (i), lesion alone (ii), lesion with naïve MSCs (iii), lesion with 
chondrogenically-induced MSCs (iv) and lesion with chondrogenically-induced and PEMF-
stimulated MSCs (v).
Materials and Methods
Cell Culture Study
Isolation and expansion of MSCs. In total, 50 ml of blood was collected in sterile EDTA tubes from the vena jugularis of three different adult donor horses, which were tested for different transmittable diseases at Böse laboratory (Harsum, Germany), as previously reported [22]. Approval of Global Stem cell Technology’s 
ethics committee was obtained (EC_2012_001). In order to isolate mesenchymal stem cells (MSCs), the blood sample was centrifuged at 1000 G for 20 minutes and the buffy coat was collected and diluted 1:2 in 
phosphate buffered saline (PBS) 1x. Afterwards, this suspension was gently layered on an equal amount of 
Percoll® density gradient (GE Healthcare) and isolated cells were further cultured in expansion medium 
consisting of DMEM low glucose + 20% FCS + 50 units/ml penicillin, 50 µg/ml streptomycin and 125 ng/ml 
amphotericin at 37°C and 5% CO2 and characterized as MSCs [23]. During the expansion phase, the culture 
medium was changed every two days and cells were subcultured at 70% confluency with 0.25% trypsin. All 
three horses were used in the cell culture study, whereas a single donor horse with the highest MSC yields was used as a source of allogeneic stem cells for the organ culture study.
For quality control purposes, an immunophenotypic characterization [23] of all donor MSCs was performed at passage 5 (P5) and P10. Briefly, untreated as well as chondrogenically-induced MSCs were 
tested by flow cytometry for the following stem cell markers: mouse anti-human CD29-APC (Biolegend), 
mouse anti-horse CD44-FITC (AbD Serotec) and mouse anti-horse CD90 PE-Cy7 (VMRD); and for the 
adult blood cell (negative) markers: mouse anti-human CD45 RPE-Cy5.5, mouse anti-horse major 
histocompatibility complex (MHC) type II-PE and monocyte/macrophage mouse anti-human macrophages-
Alexa 488 (all from AbD Serotec). Cross reactivity of negative markers with equine epitopes was assessed using equine peripheral blood mononuclear cells as previously reported [23].
Stimulation of MSCs (chondrogenic induction, PEMFs). At P4, MSCs were seeded for either standard expansion, chondrogenic induction or chondrogenic induction in combination with stimulation with pulsed 
electromagnetic fields (PEMFs). Cells were chondrogenically induced as previously reported [19, 20] by culturing 6.7x103 MSCs/cm² until the next confluency in a medium consisting of DMEM LG, 20% FCS, 1% 
AB/AM (Penicillin-Streptomycin-Amphotericin B), 1.7x10-4 % insulin-like growth factor (IGF)-I and 1.0x10-5 % transforming growth factor (TGF)-β. The seeding protocol was dependent on the type of study (see below):For the cell culture study (Fig. 1) that aimed at detecting the effect of chondrogenic induction and 
PEMF treatment on the expression of cartilage-specific markers, MSCs were seeded at a density of 1 x104 
MSCs/cm² in T25 flasks. For the organ culture experiments in which the aim was to analyse the regenerative 
capacity of MSCs as a function of treatment (induction, PEMF, loading, seeding density), MSCs were seeded at a density of 1 x104 MSCs/cm² in T75 flasks. In order to obtain a sufficient number of cells for seeding 2 different cell densities onto created lesions (0.5 or 1 x106 MSCs per cartilage sample, 9 cartilage samples to 
be treated with MSCs), nine T75 flasks were prepared for each of the 3 conditions. The experimental set-up is illustrated in Fig. 1.
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For both experiments (cell/organ culture), PEMF stimulation at 1mT and 0.5mT was applied to the respective samples for a single exposure of 10 minutes using a custom-made device [24]. Growth factor-based chondrogenic induction was conducted as previously described [19, 20].
Analysis of changes in chondrogenic marker gene expression. In the cell culture study, changes in the 
gene expression of the chondrogenic markers oligomeric matrix protein (COMP), aggrecan (ACAN) and 
collagen type II (COL II) upon stimulation of MSCs with chondrogenic medium with or without PEMF were 
analysed by qPCR. As indicated in Fig. 1, MSCs were cultured in normal expansion medium or induction 
medium for 6, 24 or 72 hours of culture before being lysed in 1 ml of Trizol (Invitrogen) and RNA was 
isolated by standard chloroform phase separation (250 µl, Sigma-Aldrich) as previously described [25]. 
RNA was quantified on the Nanodrop Lite (Fisher Scientific) before reverse transcribing 1 µg of RNA into 
cDNA (10 minutes at 25°C, 120 minutes at 37°C), using the TaqMan Reverse Transcription Reagents Kit 
(Life Technologies). cDNA was mixed with equine specific primers (Applied Biosystems, Assays on Demand: 
COMP = Ec03468079_g1, ACAN = Ec03469667_m1, COL II = Ec03467386_g1, GAPDH = Ec03210916_gH) 
and PCR Fast Master Mix (Applied Biosytems) and gene expression was analysed in triplicate on the Biorad 
CFX96 Touch Real-Time PCR detection system as previously reported [19].
Values were normalized to GAPDH (house-keeping gene) and are presented as fold change relative 
to uninduced MSCs (i.e. MSCs in expansion medium without PEMF treatment), using the comparative CT method (= 2-∆∆CT method). 
Organ Culture Study
PKH 26 labeling of MSCs. For the organ study, MSCs were cultured in normal expansion medium 
or induction medium in the dedicated samples as indicated in Fig. 1. Upon 60% confluency, MSCs were 
harvested by trypsin treatment and fluorescently labeled with the PKH26 Red Fluorescent Cell Linker Kit 
for General Cell Membrane Labeling according to the manufacturer’s protocol (Sigma-Aldrich) to allow 
long-term cell tracking upon seeding onto cartilage samples. Briefly, MSCs from one treatment condition were pooled, centrifuged at 300 G for 8 minutes, counted by hemacytometer and aliquoted into nine cell suspension portions (= 3 horses per experiment at 3 time points per treatment) of either 0.5 or 1 x106 MSCs 
each (to be seeded onto one cartilage explant each). After centrifugation, individual MSC samples were resuspended in 50 µl of DILUENT C, followed by addition of the same volume of PKH26 stain and incubated 
for 5 minutes with periodic mixing. After incubation, 100 µl of FCS was added to block the reaction and 
labelled MSCs were retrieved by centrifugation (400 G, 5 minutes) following one wash cycle with PBS. 
In a pilot study, the sustainability of the PKH26 labelling of the herein used cell type was examined and 
confirmed in 2D culture for up to 18 days (data not shown).
Sampling and incision of cartilage explants. At the slaughter house cartilage explants were aseptically excised from the patellar cartilage from six slaughtered horses between 4 and 21 years-old (4 mares and 2 
Fig. 1. Study outline assessing peripheral 
blood-derived MSCs in a cell and organ culture study.
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geldings) using an 8mm biopsy punch (n=30 per horse). The biopsies were removed from the subchondral 
bone with a scalpel blade, placed separately in 15 ml tubes containing sterile PBS plus penicillin (100 units/ml), streptomycin (100 µg/ml) and amphotericin (250 ng/ml) and transported to the laboratory. Samples 
were rinsed with the same solution under the laminar flow and individually placed in 24 well plates with 1 ml of expansion medium (see above) to keep samples hydrated. One explant at a time from the lesion groups was removed from the well, positioned on a sterile gauze and treated with a 1.5mm deep incision in the centre of the biopsy (2 parallel cuts of 4mm length each, plus 2 identical cuts in perpendicular plane as shown in Fig. 2), created through a number 15 scalpel blade with a custom-made holder to control depth of incision. On top of the front side of each biopsy, an oblique 3mm punch biopsy lesion was created for histological orientation.
MSC application onto cartilage explants. Cells were washed once, centrifuged at 400G for 5 minutes and resuspended at a dose of 0.5 or 1 x105/µl in 10 µl of bioreactor medium (expansion medium with penicillin (100 units/ml), streptomycin (100 µg/ml) and amphotericin (250 ng/ml)).
Biopsies were positioned into 24-well plates containing 200 µl of bioreactor medium, with the injured side (if applicable) facing upwards. 1 x 106 of the PKH 26 labelled MSCs from the respective treatment 
groups were resuspended in 10 µl of expansion medium and slowly seeded on top of their respective explant. The other half of the explants were covered with 0.5 x 106 cells in 10 µl of expansion medium. In 
cell-free samples, 10 µl of pure expansion medium was added to the explant. After allowing MSCs to attach 
to the explants for approximately 20 min in the incubator, 800 µl of bioreactor medium was carefully added per well in order to cover the whole sample with medium.Fourteen hours later, the explants were brought to new wells with fresh media and non-adhered cells 
were visualized and photographed using a fluorescence microscope. In order to determine the percentage 
of MSCs that attached to the cartilage explant, the media of the old wells was collected and cells attaching to the plastic surface were harvested by trypsin treatment and pooled with the culture medium, followed by cell counting.All cartilage explants were positioned in new wells with fresh medium each day and maintained 
at 37°C with 5% CO2, independent of whether mechanical loading was applied, or not (see below). The 
remaining 24-well plates were analysed each day for floating and detached cells.
Loading of cartilage explants. 40 hours after the initial seeding, half of the cartilage explants that were 
assigned to daily physiological loading were exposed to their first loading cycle at 37°C, while non-loaded samples were maintained in the incubator. For physiological dynamic loading of cartilage explants, a custom-
made bioreactor was used that allows simultaneous loading of six specimens at a time [26]. Briefly, cartilage explants were positioned between two metal plates of a sterile loading device positioned in 50 ml Falcon tubes containing 20 ml of bioreactor medium to fully cover the specimens throughout the loading phase. 
Dynamic loading was performed on the Instron E10000 (Instron International) for 1 hour a day at 40 N per explant (1 Hz) and the same time point each day. After 1, 5 and 14 days, the respective samples (as well as 
the unloaded samples) were fixed for histological analysis (see below).
Histological scoring of cartilage explants. At the respective time point (day 1, 5 and 14), the specimens were 
fixed in neutral buffered 10% formalin, embedded in paraffin, sectioned at 4 µm thickness and stained 
Fig. 2. 8mm cartilage punch biopsies of 3mm thick-ness were removed from the equine femoropatellar joint (A). Two parallel cuts of 4mm length were cre-ated in the horizontal and vertical plane creating a central grid (B). On top of the front side of each biop-sy, an oblique 3mm punch biopsy lesion was created for histological orientation (B).
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with Hematoxylin & Eosin, Safranin O and Alcian Blue. All sections were blindly scored by an anatomical pathologist (RF). The following parameters were considered: lesion presence (0 = not present or 1 = 
present); surface cell adhesion (0 = not present or 1 = present); cell integration (0 = not present or 1 = 
present); number of cell layers; chondrocyte necrosis (0 = no, 1 = moderate or 2 = severe); chondrone 
formation grade (0 = no, 1 = moderate or 2 = excessive); chondrone density (1 = 2 cell layers, 2 = 2 to 5 cell 
layers, 3 = more than 5 cell layers); lesion filling (0 = no, 1 = moderate or 2 = extensive); clump presence (0 = not present or 1 = present) and number of clump layers.
Statistical analysis
For the cell culture study, gene expression of treatment groups (induction, PEMFs) was analysed 
based on a mixed model with horse as random effect and time, medium and/or PEMF stimulation and their 
two-way interaction as categorical fixed effects. The F-test at 5% significance level and Tukey’s adjustment method were used for multiple comparisons.
For the organ culture study, the stratified Wilcoxon rank sum test for response variables with more 
than two levels and the stratified McNemar test for response variables only two levels were used. Loaded explants were compared with unloaded explants stratifying for horse, treatment and time. Treatments were compared stratifying for horse and time and only using data without loading. Finally, time points were compared stratifying for horse and treatment and only using data without loading.In order to compare the two doses, Student T-test was used to compare the average horse values (averaged over time, treatment and loading).
In all analyses, a significance level of 5% was used.
Results
Cell Culture Study
MSC response to chondrogenic induction. The effects of chondrogenic induction medium 
were analysed on the gene expression level (mRNA expression of COMP, ACAN and COL II) as well as on the protein level (Alcian Blue staining, counterstained with Hematoxylin for visualizing unstained cells). PCR revealed an increase in cartilage specific genes after 
chondrogenic induction of the MSCs in three different horses (Fig. 3A). While ACAN expression increased only 2-3 fold upon exposure to induction medium, which was not 
statistically significant (p = 0.2300), COMP expression significantly increased ~5-6 fold (p 
= 0.0488). In contrast, no considerable effects were observed for COL II at any of these early time points, indicating limited chondrogenic induction (Fig. 3A).
Flow cytometry revealed no significant changes in the percentage of positive (CD29, 
CD44 and CD90) and negative (CD45, MHC II and monocyte/macrophage marker) stem cell 
markers over time (p = 0.37) nor after chondrogenic induction at P5 (p = 0.51) and P10 (p 
= 0.28) in all horses (Fig. 4A & B). This confirmed maintenance of MSC immunophenotypic properties over the course of 72 hours, hence supporting the notion of early chondrogenic 
induction. A spindle-shaped morphology could be noticed in uninduced MSC cultures (Fig. 
4C), whereas chondrogenic induced MSCs displayed a more rectangular morphology (Fig. 
4D). Alcian Blue staining confirmed the presence of glycosaminoglycans in the chondrogenic-
induced group (Fig. 4D), whereas no blue staining was observed in MSCs cultured in 
expansion medium (Fig. 4C).
MSC response to PEMF. COL II expression in MSC cultures exposed to 1mT of PEMFs for 
10 minutes increased significantly (p = 0.0405) after 24 hours in chondrogenic induction 
medium (Fig. 3B). PEMF exposure of MSCs cultured in expansion medium at either 0.5 or 
1mT amplitudes did not result in a significant increase (p = 0.8521) in any of the evaluated 
cartilage genes (i.e. ACAN, COL II and COMP) at any of the time points in comparison to 
unstimulated MSCs (Fig. 3C presents 24 hour time point as example). In contrast with 
0.5mT, the 1mT stimulated MSCs cultured in chondrogenic induction medium resulted in 
a significant increase in COL II expression (Fig. 3D), revealing a culture medium- and PEMF 
dose-dependence. Hence, at 24 hours PEMF stimulation was able to significantly enhance 
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COL II expression. We next tested the ability of the combination of PEMFs and induction to 
improve the regenerative capacity of MSCs in an organ culture.
Organ Culture Study
PKH26 labelling and cell adhesion. PKH26 labelled MSCs could be visualized in more than 90% of the cells until day 18 after culturing in control wells, indicating a suitable staining for the 14 day explant experiment. At 14 hours after adding the cells on the explants, 
non-adhered cells clearly contained the fluorescent label as confirmed by fluorescence microscopy analysis (Fig. 5). Table 1 indicates the percentage of cells that initially did not attach to the cartilage explants of the six horses before loading, shown separately for each study group. In explant cultures designated for loading, an average of 38.6 ± 14.0% of the cells was not able to attach (Table 1). For unloaded explants this remained within the same range (35.9 ± 12.5%). In the low (0.5 x106 MSCs) and high (1 x 106 MSCs) seeding density groups, an average of 41.3 ± 12.6% versus 33.1±12.8% of the cells did not attach to the explants, 
respectively (Table 1). No significant differences in cell losses before loading were found 
between explants treated with high and low density of MSCs. After 24 hours, no more cells were detected in the supernatant or at the bottom of the wells. At each time point, adhered 
MSCs were visualized with a fluorescence microscope; however, no more red fluorescent signal could be detected after tissue sectioning.
Histological results of loaded cartilage explants. Daily compressive physiological loading was applied to cartilage explants in order to enhance the in vivo comparability. Although loading was only as high as 40 N for 1 hour per day at 1 Hz, it had severe effects on the 
presence of MSCs (independent of the pre-treatment of cells). Taking all the time points together, after exposure to loading, only 1.9% or 1 out of 54 (= 3 time points x 6 horses x 
3 MSC treatment groups) cartilage explants demonstrated adherent MSCs on their surface 
Fig. 3. RT-PCR for gene expression of ACAN, COL II and COMP. Increase of cartilage gene expression after 
chondrogenic induction in comparison to uninduced MSCs (A). Effect of PEMF on COL II expression of un-
induced and chondrogenic induced MSCs at different time points (B). Effect of 0.5 mT and 1 mT of PEMF 
stimulation on the expression of different cartilage genes in uninduced (C) and chondrogenic induced MSCs 
(D) at 24 hours. Values are given as the mean of three measurements ± SEM; * indicates p < 0.05.
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(Fig. 6) which resulted in absence of clump formation in the loaded group. Consequently, 
lesion filling was only observed in 3.7% or 2 out of 54 cartilage explants (Fig. 6).
Fig. 4. Flow cytometry confirmed a positive expression for CD29, CD44 and CD90 compared to isotype 
control (A), whereas no expression for a monocyte/macrophage marker, major histocompatibility complex 
(MHC) type II and CD45 could be observed at P5 and P10 on chondrogenic induced MSCs (B). Light micro-
scopic images of MSCs in their undifferentiated state (C) and chondrogenic induced state (D) after Alcian 
Blue staining. Glycosaminoglycan production can be noticed after induction. Scale bars represent 50µm.
Fig. 5. Phase contrast 
(A), fluorescence (B) and 
overlay (C) images of 
PKH26-labelled MSCs in the different treatment groups at 14 hours after seeding: uninduced (I), chondrogenic induced 
(II) and PEMF stimulated chondrogenic induced 
(III) MSCs. Scale bars 
represent 50 µm.
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Histological results of unloaded explants. Taking all three time points of unloaded MSC-
treated groups (iii, iv and v) together, adherent MSCs were present in 92.6% of the explants 
(= 50/54 = (Day 1 = 18/18) + (Day 5 = 17/18) + (Day 14 = 15/18)), which is significantly 
more than 1.9% in the loaded explants (p < 0.0001). It made it also possible to histologically score and compare the different unloaded treatment groups. For all the scored parameters, 
no significant differences between chondrogenically-induced MSCs with or without PEMF 
stimulation could be demonstrated. On the other hand, in chondrogenic induced MSC 
groups (with or without PEMF), a homogenous cell distribution and no cell clumps were 
more characteristic, whereas 7 out of 18 (39%) uninduced MSC treated cartilage explants 
exhibited cell clumps of at least 8 cell layers thickness. Clumping incidence was significantly different from the other treatment groups (p = 0.0156) and was independent of cell seeding number. The number of explants with lesion filling (40.7% = 22/54) significantly decreased 
(p = 0.0156) in the unloaded group from day 5 (n=11/18) to day 14 (n=4/18), in contrast to 
what was observed from day 1 (n=7/18) to 5 (p = 0.2188). Although no more clumps were noticed in any explant culture at day 14 (Fig. 7), the number of explants that demonstrated 
adhered MSCs on their surface did not significantly alter over time (p1->5 = 1.000, p5->14 = 
Table 1. Percentage of cells that initially did not attach on the loaded (L) and unloaded (U) carti-lage explants at 14 hours after seeding and before 
the first loading session
Fig. 6. Representative images of loaded versus unloaded cartilage 
explants at 40-fold magnification. Different groups are illustrated: no 
lesion without MSCs (A), only a le-
sion without MSCs (B), lesion with 
MSCs (C), lesion with chondrogenic 
induced MSCs (D) and lesion with 
PEMF stimulated chondrogenic in-
duced MSCs (E). Boxes represent 
200 fold magnifications.
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0.6250, Fig. 7). The adhered non-clumped cell layers also remained relative constant over time (p1->5 = 1.000, p5->14 = 0.1250, Fig. 7).Taking all treatment scores in unloaded conditions together for the three horses treated with 0.5 x 106 MSCs (low density) versus the other three horses treated with 1 x 106 MSCs 
(high density), significantly more cartilage explants demonstrated lesion filling (p = 0.0022) 
and surface adhered MSCs (p = 0.0161) in the low density group. The average score for 
lesion filling was 0.67 per low density treated cartilage explant and 0.15 for the high density 
treated explants. Concerning adhered MSCs, an average score of 1.00 demonstrated presence 
of MSCs on the surface of each low density explant, whereas this was not the case for the high 
density MSC application (average score of 0.85). On the other hand, no significant difference concerning integration (p = 0.6779), cell layers (p = 0.6974), clump formation (p = 0.6433) and clump layers (p = 0.6340) could be noticed between both.
Discussion
In the present study, peripheral blood (PB)-derived mesenchymal stem cells (MSCs) 
of three horses were successfully isolated and chondrogenically induced as confirmed by 
PCR and histology. Briefly, flow cytometry confirmed no loss of the typical MSC markers during the predifferentiation process. Half of the 180 cartilage explants were loaded in order 
to assess the cartilage integrity and integration capacities of fluorescently labelled MSCs 
under physiological compression at three time points (day 1, 5 and 14). Proliferation and 
differentiation are largely mutually exclusive processes in chondrogenesis. Chondrogenic 
Fig. 7. Representative images of unload-ed explants at a 40 and 200 fold magni-
fication. Cartilage explants treated with 
uninduced MSCs contain clumps at day 1 (A) and day 5 (B), whereas clumps 
detached before day 14 (C). Cartilage explants after treatment with chondro-
genic induced MSCs demonstrate a ho-mogenous cell adhesion which remains constant from day 1 (D), towards day 5 
(E) and day 14 (F).
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induction was performed for only three days in a 2-dimensional culture system in order 
to maintain MSC proliferative capacity in an injectable cell-based product undergoing the 
initial stages of differentiation. The conservation of MSC markers and limited cartilage gene upregulation both indicate that the cells were in a prechondroblastic stage and not fully differentiated yet.  
In order to track MSCs, labelling with the membrane incorporating substance PKH26 was performed, which was considered a suitable alternative to intranuclear labelling 
methods (e.g. green fluorescent protein GFP labelling) due to its well-described low toxicity and labelling sustainability in progenitor-like cells [27-30]. A preliminary experiment on 
PB-MSCs in 2D culture confirmed detectability of the fluorescent signal until day 18 (data not shown), yet moderately diluted due to cell division, as previously reported for pig 
chondrocytes [31]. Although successful fluorescent labelling of MSCs with PKH26 could 
be confirmed at the beginning of the organ culture study (on day 1 after seeding), the 
fluorescent signal could not be detected in the histological sections of the seeded cartilage 
explants. In contrast, other studies have previously described successful fluorescence-based 
detection of implanted, PKH-labelled MSCs and chondrocytes after 6 weeks (sheep) [32] or 12 weeks (mice) [31] in vivo, respectively. The exact reasons for the loss of fluorescent signal will have to be investigated in detail in future studies, but may be related to differences in the experimental condition and histological processing.
Although fluorescence labelling of MSCs was not detectable in the cartilage explants, 
MSCs could be identified based on their typical spindle-shaped morphology as well as by 
immunohistochemistry staining for MSC markers (data not shown). The spindle-shaped 
morphology at each analysis time point (after adding to the explants) indicates that MSCs did not attain fully differentiated chondrogenic features during two weeks of explant culture. This might be explained by the brief culture period (before adding to the explants) and the fact that, after a three-day induction period, no more cartilage inducing growth factors were 
used. A previous study using cartilage specific medium reports chondrogenic differentiation 
of integrated porcine bone marrow-derived MSCs after 6 weeks of culture in cartilage explant defects coated with agarose hydrogels [33].
In this study, the effects of chondrogenic induction, PEMF treatment, seeding density 
and mechanical loading on MSC adherence and functionality were analysed. After mechanical 
loading, significantly (p < 0.0001) less explants exhibited lesion filling (3.7% vs 40.7%) or 
cell adherence (1.9% vs 92.6%). As physiological pressures (ca. 0.8 MPa) were applied that 
are also expected to arise during moderate training, this finding indicates that mechanical 
loading - if applied soon after implantation/injection - may mechanically interfere with the 
integration of MSCs into isolated explants and undermine a potentially beneficial outcome. 
Cartilage contact pressures of 0.8 MPa can be considered to be in the range of that acting 
in vivo on e.g. the equine stifle joint during normal ambulation, as peak pressures up to 1.5 
– 2.0 MPa have been measured by Fowlie et al. [34]. Due to the weight and physiology of 
equine joints together with the robustness of equine subchondral bone [35], our findings may expose some restrictions for future clinical application. However, it has been reported that joint loading is highly dependent on the joint type and joint compartment [36]. In the present study, patellar cartilage was taken and it has been reported that this compartment is 
relatively unloaded during stall confinement and supervised walking, which could explain the sensitivity to loading [36, 37]. The weight-bearing medial and lateral compartments on the other hand experience more in vivo loading, which might compromise the treatment. Further 
in vitro bioreactor tests with different loading patterns as well as tests under physiological circumstances will need to be performed to eventually make exercise recommendations for 
MSC-treated OA patients.
Chondrogenically-induced MSCs displayed superior adhesion and integration capacity 
in comparison to uninduced MSCs in this study. Homogenous layers of chondrogenic induced 
MSCs could be noticed all over the explants, whereas in 39% of the uninduced MSCs large clumps of at least 8 cell layers were observed predominantly at areas on top of the explants 
which detached before day 14. Overall, a more efficient cell adhesion and integration 
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could be noticed in explants seeded with chondrogenic induced MSCs. On the other hand, the adhered non-clump cell layers remained relative constant over time, independent of 
predifferentiation. The beneficial effect of predifferentiation has also been reported in vivo in 165 horses, where clinical outcomes were improved upon chondrogenic predifferentiation [20].
Seeding density also had a significant effect on the outcome (in unloaded specimens). Interestingly, low cell densities (27 replicates = 3 horses, 3 treatment circumstances at 3 time 
points) demonstrated significantly more lesion filling than higher cell density treatments. In 
addition, all low cell density treated explants demonstrated adhered MSCs to their surface, whereas this was not the case for the high cell density treatment. Although dose-dependent 
effects have been reported for allogeneic MSCs for the treatment of myocardial infarction in rats [38] and graft versus host disease in mice [39], others have also demonstrated a superior 
outcome using a lower density of allogeneic MSCs for treatment of injured medial collateral ligaments of rat knees [40] or for the treatment of human knee osteoarthritis [41]. As clump formation did not differ between the cell density groups, the difference was unlikely due to steric obstruction. Hence, more research is warranted to identify the optimal cell density 
of MSC treatments (rather than the lowest effective dose) such as dose-response studies typical for clinical medicine.
Whereas predifferentiation, loading and seeding density had significant impact on this 
study’s outcome measures, PEMF treatment did not obviously improve any of the evaluated cartilage regeneration parameters in this organ culture study. On the other hand, in the cell 
culture study an increase in COL II expression was observed in response to PEMF stimulation. 
Alternative approaches to improve regeneration capacity in explants treated with PEMFs may 
include: 1) increasing exposure amplitude; 2) increasing exposure duration; 3) increasing 
number of exposures to a value greater than 1; 4) exposing MSC-seeded explants directly 
to PEMFs or; 5) a combination of the above. In fact, Esposito et al. have previously reported 
induction of chondrogenic differentiation upon PEMF treatment [14] and several in vivo 
studies have demonstrated beneficial effects of this therapy on clinical symptoms of animals and humans with osteoarthritis [11, 12]. It has to be mentioned though that these studies applied 6 weeks of daily treatment of the injured joint, whereas our study employed single 10 
minute prestimulation of chondrogenically induced MSCs and unstimulated ex vivo cartilage 
explants. Future research focussing on PEMF-treated cartilage explants might provide more 
insights into the mechanisms of PEMF stimulation at a tissue level. Such studies might also 
clarify whether PEMF-treatment evokes cellular cascades of non-cartilage origin.
In conclusion, our results indicate that chondrogenic induction was successful in PB-
MSCs and resulted in improved outcome with regard to MSC adhesion and integration. 
PEMF-treatment was able to enhance the expression of COL II in chondrogenically-induced 
MSCs, which was previously insensitive to induction alone. The application of lower densities 
of MSCs to explants proved superior to higher MSCs densities, whereas PEMF-treatment 
exerted no obvious benefit over induction alone in explants. Importantly, immediate 
physiological loading negatively influenced MSC adhesion to explants, which may have 
significant implications for the early rehabilitation strategy of patients undergoing MSCs treatment for cartilage regeneration. Future studies will aim to analyse the time-dependent 
effect of loading of MSC-seeded cartilage explant.
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